Mitsui Chemicals Inc. (TYO:4183) is looking to expand R&D efforts overseas with its new testing technology for sepsis, a severe infectious disease. This comes as part of a plan to...
Pharma
Takagi Seiko Targets Growth With Production of Needle-Free Injector Parts
Takagi Seiko Corp. (TYO:4242) is aiming to leverage its precision molding technologies to expand its business in the medical device field. These efforts have already seen the Toyama Prefecture-based company...
Sumitomo Dainippon Pharma Targets GMP-Based Mass Production of Cellular Medicine
Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) is working toward the mass production of cellular pharmaceuticals for regenerative medicines derived from allogenic induced pluripotent stem (iPS) cells. Medicine produced through this...
Otsuka Pharmaceutical Plans Launch of Antipsychotic Pills With Embedded Mini-Sensors
Otsuka Pharmaceutical Co. Ltd. is targeting a U.S. rollout beginning as soon as this year for Abilify MyCite – a world-first “digital medicine” that incorporates medical devices into pills. The...
Chugai Pharmaceutical Targets Lower Investment and Maintenance Costs With Next-Gen Plant
Chugai Pharmaceutical Co. Ltd. (TYO:4519) has begun preparations for a new plant emphasizing cost and speed. The company is looking to reduce the initial investment and maintenance costs for this...
Ube Industries Plans Full-Scale Entry Into Drug Substance Market for Generics
Ube Industries Ltd. (TYO:4208) is looking to enter into the market of pharmaceutical ingredients for use in generic drugs by the end of this year. The company already engages in...
Mitsubishi Chemical Goes on Front Foot in Medical Materials
Mitsubishi Chemical Corp. is embarking on a charge in medical materials. In the area of medical compounds, Mitsubishi Chemical has developed a novel cyclic block copoylmer (CBC). Given that cyclo-olefin...
Sanyo Chemical Aims to Bolster Biomedical Operations
Sanyo Chemical Industries Ltd. (TYO:4471) is aiming to strengthen sales promotion efforts for its biomedical products. The company deploys a range of products in the field both domestically and overseas....
Eisai Eyes AI for Drug Discovery
Eisai Co. Ltd. (TYO:4523) is increasingly tapping into AI for its drug discovery research. This past June, the company began using an AI system developed in partnership with the University...
Daiichi Sankyo Sees Pillar of Growth in Next-Gen Biopharmaceuticals
Daiichi Sankyo Co. Ltd. (TYO:4568) is making antibody drug conjugates (ADCs) and other next-generation biopharmaceuticals a pillar for medium- and long-term growth. The Japanese pharmaceutical company has initiated phase 2...
Sumitomo Rubber Limits Biopharmaceutical Deterioration With New Prefilled Syringe Stopper
Sumitomo Rubber Industries Ltd. (TYO:5110) has developed a rubber stopper that inhibits deterioration in biopharmaceuticals. Liquid biopharmaceuticals are delivered to end users in prefilled syringes that already contain the drug....
Fujifilm to Test Mass Production of Microneedle Arrays
Fujifilm Holdings Corp. (TYO:4901) is looking to accelerate the practical application of microneedle arrays – a drug delivery technology whereby a sheet adheres to the patient’s skin and administers drugs...
Takeda Pharmaceutical Looks to Increase Use of Bioplastic Medicine Bottles
Takeda Pharmaceutical Co. Ltd. (TYO:4502) is aiming to increase its use of pharmaceutical packaging made with materials from plants such as sugarcane. Due to issues like quality assurance and costs...
Chemical and Material Manufacturers Eye Sustainable Growth in Health Care Sector
Chemical and material manufacturers are focusing their efforts in on the health care sector, seeing here little risk of fluctuation effects and as such expecting sustainable growth over the medium–long...
Nitto Denko Targets Life Science as Third Business Pillar
Nitto Denko Corp. (TYO:6988) is looking to rear its life science operations into a third key pillar of business. Fiscal 2017 sales for Nitto Denko totaled 856.3 billion yen ($7.82...
Taiyo Holdings Looks to Produce Drugs In-House
Taiyo Holdings Co. Ltd. (TYO:4626) has acquired long-listed drug business operations from Chugai Pharmaceutical Co. Ltd. (TYO:4519), and plans to acquire its own factory within the fiscal year to produce...
Toray Considers Seven Key Themes for New R&D Base
Toray Industries Inc. (TYO:3402) is setting out to conduct R&D initiatives for a number of cutting-edge materials, including process materials used in the production of biopharmaceuticals. The company will be...
Riken and Ricoh Prototype Artificial Bone With 3D Printing
A research group composed of members from the Institute of Physical and Chemical Research (Riken) and Ricoh Co. Ltd. (TYO:7752) has used 3D printing to develop a strong artificial bone...
Memory T Cells Found to Alter Immunological Response Based on Intensity of Antigenic Stimulation
An international research group formed by the Institute of Physical and Chemical Research (Riken), Osaka University and Yale University has discovered that the strength at which memory T cells are...
NOF Develops Monodisperse PEG for Antibody Drug Delivery
NOF Corp. (TYO:4403) has developed a monodisperse polyethylene glycol (PEG) as a drug delivery system (DDS) material usable in antibody drugs. Sales of the PEG began in March. Unlike typical...
